Minich Mac Gregor Wealth Management, LLC Amgen Inc Transaction History

Minich Mac Gregor Wealth Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 09, 2023	BUY	$229.03 - $291.01 $73,289 - $93,123	320 New	320 $0
Q2 2020 Aug 05, 2020	SELL	$197.81 - $242.74 $1.07 Million - $1.31 Million	-5,409 Closed	0 $0
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $985,736 - $1.31 Million	5,409 New	5,409 $1.2 Million
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $343,653 - $387,372	-1,900 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$178.4 - $208.25 $274,557 - $320,496	1,539 Added 426.32%	1,900 $354,000
Q3 2018 Oct 17, 2018	SELL	$185.29 - $208.89 $1,482 - $1,671	-8 Reduced 2.17%	361 $74,000
Q2 2018 Jul 13, 2018	SELL	$166.05 - $186.51 $1,660 - $1,865	-10 Reduced 2.64%	369 $68,000
Q1 2018 Jul 03, 2018	BUY	$169.43 - $198.0 $3,558 - $4,158	21 Added 5.87%	379 $64,000
Q2 2017 Jul 02, 2018	BUY	N/A	1 Added 0.28%	358 $61,000
Q3 2016 Jun 28, 2018	SELL	N/A	-1 Reduced 0.28%	357 $59,000
Q1 2016 Jun 28, 2018	BUY	N/A	8 Added 2.29%	358 $53,000
Q4 2015 Jun 27, 2018	BUY	N/A	350	350 $54,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Minich Mac Gregor Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Minich Mac Gregor Wealth Management, LLC with notifications on news.